The use of BDNF to enhance the patency rate of small-diameter tissue-engineered blood vessels through stem cell homing mechanisms

Biomaterials

Volumn 33, Issue 2, 2012, Pages 473-484

  Zeng, Wen ^a   Wen, Can ^a   Wu, Yangxiao ^a   Li, Li ^a   Zhou, Zhenhua ^a   Mi, Jianhong ^a   Chen, Wen ^a   Yang, Mingcan ^a   Hou, Chunli ^a   Sun, Jiansen ^a   Zhu, Chuhong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factors; Endothelial progenitor cells; Endothelialization; Patency rate; Tissue engineered blood vessels; Vascular matrix material

Indexed keywords

BRAIN-DERIVED NEUROTROPHIC FACTORS; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIALIZATION; PATENCY RATE; TISSUE-ENGINEERED BLOOD VESSELS; VASCULAR MATRIX MATERIAL;

BLOOD; CLONE CELLS; CLONING; ENDOTHELIAL CELLS; MAMMALS; STEM CELLS; TISSUE;

BLOOD VESSELS;

BRAIN DERIVED NEUROTROPHIC FACTOR; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CAROTID ARTERY; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MOLECULAR CLONING; MOUSE; NONHUMAN; NORMAL HUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STEM CELL; TISSUE ENGINEERING; VAGUS NERVE;

ANIMALS; BLOOD VESSELS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; RATS; RATS, WISTAR; TISSUE ENGINEERING; VASCULAR PATENCY;

RATTUS;

EID: 80055117545     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.09.066     Document Type: Article

References (38)

1. Dahl S.L., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3(68):68-69.
2. Szczech L.A., Best P.J., Crowley E., Brooks M.M., Berger P.B., Bittner V., et al. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 2002, 105(19):2253-2258.
3. Isenberg B.C., Williams C., Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ Res 2006, 98(1):25-35.
4. Derham C., Yow H., Ingram J., Fisher J., Ingham E., Korrosis S.A., et al. Tissue engineering small-diameter vascular grafts: preparation of a biocompatible porcine ureteric scaffold. Tissue Eng Part A 2008, 14(11):1871-1882.
5. Nugent H.M., Edelman E.R. Tissue engineering therapy for cardiovascular disease. Circ Res 2003, 92(10):1068-1078.
6. Heyligers J.M., Arts C.H., Verhagen H.J., de Groot P.G., Moll F.L. Improving small-diameter vascular grafts: from the application of an endothelial cell lining to the construction of a tissue-engineered blood vessel. Ann Vasc Surg 2005, 19(3):448-456.
7. Faries P.L., Logerfo F.W., Arora S., Hook S., Pulling M.C., Akbari C.M., et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 2000, 32(6):1080-1090.
8. Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231(4736):397-400.
9. Hoerstrup S.P., Kadner A., Breymann C., Maurus C.F., Guenter C.I., Sodian R., et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg 2002, 74(1):46-52. discussion 52.
10. Mertsching H., Schanz J., Steger V., Schandar M., Schenk M., Hansmann J., et al. Generation and transplantation of an autologous vascularized bioartificial human tissue. Transplantation 2009, 88(2):203-210.
11. Hristov M., Erl W., Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003, 23(7):1185-1189.
12. Rabelink T.J., de Boer H.C., de Koning E.J., van Zonneveld A.J. Endothelial progenitor cells: more than an inflammatory response?. Arterioscler Thromb Vasc Biol 2004, 24(5):834-838.
13. Zeng W., Yuan W., Li L., Mi J., Xu S., Wen C., et al. The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue-engineered blood vessels. Biomaterials 2010, 31(7):1636-1645.
14. Negi S., Nambi V. Coronary heart disease risk stratification: pitfalls and possibilities. Methodist Debakey Cardiovasc 2011, 6(4):26-32.
15. Bauters C. Pathophysiology of coronary artery disease. Rev Prat 2008, 58(14):1523-1526.
16. Ballantyne C.M., Hoogeveen R.C., Bang H., Coresh J., Folsom A.R., Heiss G., et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004, 109(7):837-842.
17. Chan S.H., Wu C.W., Chang A.Y., Hsu K.S., Chan J.Y. Transcriptional upregulation of brain-derived neurotrophic factor in rostral ventrolateral medulla by angiotensin II: significance in superoxide homeostasis and neural regulation of arterial pressure. Circ Res 2010, 107(9):1127-1139.
18. Messaoudi E., Ying S.W., Kanhema T., Croll S.D., Bramham C.R. Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci 2002, 22(17):7453-7461.
19. Boulanger L., Poo M.M. Gating of BDNF-induced synaptic potentiation by cAMP. Science 1999, 284(5422):1982-1984.
20. Kermani P., Hempstead B. Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med 2007, 17(4):140-143.
21. Donovan M.J., Lin M.I., Wiegn P., Ringstedt T., Kraemer R., Hahn R., et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000, 127(21):4531-4540.
22. Wagner N., Wagner K.D., Theres H., Englert C., Schedl A., Scholz H. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. Genes Dev 2005, 19(21):2631-2642.
23. Kermani P., Rafii D., Jin D.K., Whitlock P., Schaffer W., Chiang A., et al. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest 2005, 115(3):653-663.
24. Urao N., Okigaki M., Yamada H., Aadachi Y., Matsuno K., Matsui A., et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 2006, 98(11):1405-1413.
25. Ejiri J., Inoue N., Kobayashi S., Shiraki R., Otsui K., Honjo T., et al. Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 2005, 112(14):2114-2120.
26. Kasarskis E.J., Shefner J.M., Smith R.A., Licht J., Rosenfeld J., Cornblath D.R., et al. A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III). Neurology 1999, 52(7):1427-1433.
27. Zhu C., Ying D., Mi J., Li L., Zeng W., Hou C., et al. Development of anti-atherosclerotic tissue-engineered blood vessel by A20-regulated endothelial progenitor cells seeding decellularized vascular matrix. Biomaterials 2008, 29(17):2628-2636.
28. Andersson J., Larsson R., Richter R., Ekdahl K.N., Nilsson B. Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation. Biomaterials 2001, 22(17):2435-2443.
29. Mohan S., Mohan N., Valente A.J., Sprague E.A. Regulation of low shear flow-induced HAEC VCAM-1 expression and monocyte adhesion. Am J Physiol 1999, 276(5 Pt 1):C1100-C1107.
30. Zhu C.H., Ying D.J., Mi J.H., Zhu X.H., Sun J.S., Cui X.P. Low shear stress regulates monocyte adhesion to oxidized lipid-induced endothelial cells via an IkappaBalpha dependent pathway. Biorheology 2004, 41(2):127-137.
31. Torensma R. Blood vessels engineered from human cells. Lancet 2005, 366(9489):892. author reply 892-893.
32. L'Heureux N., Dusserre N., Konig G., Victor B., Keire P., Wight T.N., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006, 12(3):361-365.
33. Barco A., Patterson S., Alarcon J.M., Gromova P., Mata-Roig M., Morozov A., et al. Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. Neuron 2005, 48(1):123-137.
34. Jung S.H., Kim J., Davis J.M., Blair S.N., Cho H.C. Association among basal serum BDNF, cardiorespiratory fitness and cardiovascular disease risk factors in untrained healthy Korean men. Eur J Appl Physiol 2010, 111(2):303-311.
35. Caporali A., Emanueli C. Cardiovascular actions of neurotrophins. Physiol Rev 2009, 89(1):279-308.
36. Javaid A., Steinberg D.H., Buch A.N., Corso P.J., Boyce S.W., Pinto Slottow T.L., et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007, 116(Suppl. 11):I200-I206.
37. Toumpoulis I.K., Anagnostopoulos C.E., Katritsis D.G., DeRose J.J., Swistel D.G. The impact of preoperative thrombolysis on long-term survival after coronary artery bypass grafting. Circulation 2005, 112(Suppl. 9):I351-I357.
38. Whittaker C., Grist G., Bert A., Brasky K., Neighbors S., McFall C., et al. Pediatric cardiopulmonary bypass adaptations for long-term survival of baboons undergoing pulmonary artery replacement. J Extra Corpor Technol 2010, 42(3):223-231.